Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
Article in Caspian Journal of Internal Medicine (January 2022)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Utilization of Prognostic Biomarker Soluble Urokinase Plasminogen Activator Receptor in the Emergency Department: A Tool for Safe and More Efficient Decision-making
Article in Biomarker Insights (January 2022)
suPAR cut-offs for stratification of low, medium, and high-risk acute medical patients in the emergency department
Article in BMC Emergency Medicine (November 2021)